Pharmaguy™’s Twitter Stream – Q1 2009

Pharmaguy™ is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News

Profile of Pharmaguy™’s Twitter Followers

Pharmaguy™ is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News

Brian Fox: The Digital Gap Between Pharma and Other Industries

In this 2-minute audio snippet, Brain Fox, Senior Partner at McKinsey, talks about how the pharma industry lags other industries in its investment in digital technology and in testing the effectiveness of its digital marketing campaigns.

PharmaGuy of Newtown Supports Science

John (PharmaGuy) Mack was a speaker at the April 22,2017, March for Science in Doylestown, PA. He spoke of the need for more scientists to get involved in local politics and for all citizens to elect pro-science leaders and ensure that they rely on evidence, not beliefs, when making decisions about our health, our environment, and our general well-being.

A Shower of Oxycodone in West Virginia, a Flood of Drug Adverse Event Reports...

In this 4.5-minute audio snippet, Pharmaguy discusses how West Virginia and other rural areas are being showered with opioids by drug companies, which could be a major cause in the current flood of drug adverse events.

The Misleading Marketing of “Low-T” Drugs

A conversation with Adriane Fugh-Berman, MD, Associate Professor at Georgetown University Medical Center and Director of PharmedOut.

Pharmaguy™’s Twitter Stream – Q2 2013

Pharmaguy™ is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News

Pharmaguy™’s Twitter Stream – Q1 2010

Pharmaguy™ is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News

Pharmaguy™’s Twitter Stream – Q1 2012

Pharmaguy™ is a Pharma Marketing Pundit & Critic, Blogger & Publisher of Pharma Marketing News

Paul Ivans: Seeking Clarification on FDA Guidance Regarding Placement of Promotional Messages on 3rd-Party...

In this 3-minute audio snippet, Paul Ivans, President and CEO, Evolution Road, LLC, reviews comments he submitted to the FDA regarding clarification of FDA's intent on how it will regulate the placement of pharma promotional messages on independent 3rd-party Web sites.
- Advertisement -